CRUK Cambridge Centre

  • Sarah Bohndiek wins SPIE Early Career Achievement Award
  • Mapping oesophageal cancer genes leads to new drug targets
  • Cambridge researcher backs World Cancer Day - Mon 4 Feb - for his dad
  • Cambridge scientists to work on £20 million Grand Challenge project
  • Comprehensive new online calculator predicts breast cancer risk
  • New clinical trial to develop breath test for multiple cancers
  • Clinical trial found my cancer and saved my life

The CRUK Cambridge Centre is a dynamic collaboration of researchers, clinicians, and the pharmaceutical and biotech industries based in the Cambridge area. We combine world-class science and technology with excellent patient care to pioneer new ways to prevent, detect and treat cancer.

By working together across different disciplines, we are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

Patient care and clinical research
We offer a leading cancer care specialist service at Addenbrooke’s Hospital. We are committed to translating our clinical research to improve patient outcomes by recruiting the highest proportion of patients onto clinical trials in the UK.
Over 140 research groups work together across traditional academic, commercial and clinical boundaries. We connect cutting-edge science and technology from different disciplines to shed new light on preventing and controlling cancer.
Education and training
We educate and train the next generation of cancer scientists and clinicians. Working with the University of Cambridge we provide a stimulating learning environment for undergraduates, graduates, and postdoctoral researchers.

Subscribe to Centre News Latest news and events from CRUK Cambridge Centre

St Neots gran helps scientists to take on £20 million Grand Challenge looking at new ways to tackle cancers linked to chronic inflammation.
Cambridge researchers discover that estrogen-dependent gene expression in breast tumour cells is not cyclical, as previous studies suggested.
New centre will use CRISPR technology, big data and clinical insights to discover new drugs for cancer patients.